Preclinical Studies of the Lemon Hill as a Multi-approach Antioxidant and Antidiabetic Plant: Citrus Pseudolimon Tanaka

Abstract

ABSTRACT The antioxidant and antidiabetic activity of methanol leaves extract (CPMLE) and ethyl acetate fraction (CPEALF) of lemon hill (Citrus pseudolimon) was examined on key enzymes (α-glucosidase and α-amylase) in type-2 diabetes. In-vivo antidiabetic activity was evaluated in streptozotocin (STZ)-induced diabetic rats against CPMLE and CPEALF. Methanolic extract of the plant was effective against 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging (IC50 = 313.20 µg mL−1), reducing power (IC50 = 366.69 µg mL−1), and H2O2 scavenging (IC50 = 498.26 µg mL−1) and phosphomolybdate radical scavenging activity (IC50 = 508.02 µg mL−1). Ethyl acetate fraction demonstrated DPPH radical scavenging (IC50 = 259.33 µg mL−1), reducing power (IC50 = 268.91 µg mL−1), and H2O2 scavenging (IC50 = 476.39 µg mL−1) and phosphomolybdate radical scavenging activity (IC50 = 278.60 µg mL−1). C. pseudolimon methanol extract had inhibitory activity against α-glucosidase (IC50 = 350.09 µg mL−1) and α-amylase (IC50 = 291.17 µg mL−1) enzymes. Oral administration of CPMLE and CPEALF reduced elevated fasting blood glucose, lipid levels, and oxidative stress along with Hb1AC level.